LMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alpha.

LMP-1, an Epstein-Barr virus membrane protein expressed during latent infection, has oncogenic properties, as judged from its ability to transform B lymphocytes and rodent fibroblasts. LMP-1 induces the expression of bcl2, an oncogene which protects cells from apoptosis, as well as of genes encoding...

Celý popis

Podrobná bibliografie

Vydáno v:	J Virol
Hlavní autoři:	Herrero, J A, Mathew, P, Paya, C V
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1995
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188885/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7884865/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.69.4.2168-2174.1995
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!